Did you chk out ONVO .....developing liver cell structures using 3D printing techniques ...for liver toxicity drug tests.
All orally administered drugs must pass a liver tox test ..so its potentially big biz.
AK....ONVO looks promising but the Fognac's (brothers??) who have 12.5 million of the shares and apparently founded the company, look kind of like promoters with alot of other "irons" in the fire in addition to ONVO. Both look terribly bright and Andras is a Harvard MBA with honors, etc, but I'd be more impressed if the "scientific" development team had some type of track record in 3D tissue modeling, or I knew more about "ZenBio" etc. Frankly, given where they seem to be at today, it
looks like the stock has gotten quite a bit ahead of fundamentals, but if you got in under 3 not a bad
#$%$ shoot. I'd be more confident if ONVO was the only company these Andras guys were involved in, but it's not.
Thanks for the mention and I'll watch it, and keep the ideas coming!